Earnings Call · Q3 FY2022·2022-11-01

Q3 22EPS +29.17%·Rev n/aQ2 22EPS +16.67%·Rev n/aQ1 22EPS +13.04%·Rev n/aQ4 21EPS +100.00%*·Rev n/a⚠ consensus missing

EXELIXIS, INC. EXEL

Susan Hubbard — Investor Relations Host

Mike Morrissey — President and Chief Executive Officer

Chris Senner — Chief Financial Officer

P.J. Haley — Executive Vice President of Commercial

Vicki Goodman — Executive Vice President of Clinical Development or similar clinical development leadership

Peter Lamb — Head of Business Development or similar senior BD role

+1.3%1d on move date+3.8% vs SPY3d−2.0%5d−1.4%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EXEL calls or request research access.

More EXEL calls Browse calls Request research access